SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-17-035598
Filing Date
2017-10-06
Accepted
2017-10-06 14:46:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 106780
  Complete submission text file 0000000000-17-035598.txt   147751
Mailing Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 866-8548
Denali Therapeutics Inc. (Filed for) CIK: 0001714899 (see all company filings)

IRS No.: 463872213 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2836 Biological Products, (No Diagnostic Substances)